Advanced BioMedical Technologies, Inc.
ABMT
$0.0002
-$0.0004-66.67%
| 07/31/2021 | 04/30/2021 | 01/31/2021 | 10/31/2020 | 07/31/2020 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.00K | 6.00K | 8.50K | 201.70K | 14.50K |
| Total Receivables | 46.80K | 53.20K | 56.40K | 29.30K | 34.70K |
| Inventory | 188.80K | 159.00K | 122.20K | 100.00K | 80.40K |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 242.60K | 218.20K | 187.10K | 331.00K | 129.60K |
|
|
|||||
| Total Current Assets | 242.60K | 218.20K | 187.10K | 331.00K | 129.60K |
| Net Property, Plant & Equipment | 153.90K | 160.50K | 144.70K | 138.30K | 152.10K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 396.50K | 378.70K | 331.80K | 469.20K | 281.60K |
|
|
|||||
| Total Accounts Payable | 1.16M | -- | -- | 200.00 | -- |
| Total Accrued Expenses | -- | -- | -- | 374.70K | -- |
| Short-term Debt | 6.35M | 6.25M | 6.14M | 5.59M | 5.95M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.80K | 14.30K | 20.30K | 28.00K | 34.90K |
| Total Finance Division Other Current Liabilities | 1.06M | 2.08M | 2.00M | 1.88M | 1.28M |
| Total Other Current Liabilities | 1.06M | 2.08M | 2.00M | 1.88M | 1.28M |
| Total Current Liabilities | 8.58M | 8.35M | 8.16M | 7.86M | 7.26M |
|
|
|||||
| Total Current Liabilities | 8.58M | 8.35M | 8.16M | 7.86M | 7.26M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 6.35M | 6.25M | 6.14M | 5.59M | 5.95M |
| Capital Leases | -- | -- | 3.70K | 7.00K | 10.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.58M | 8.35M | 8.16M | 7.87M | 7.27M |
|
|
|||||
| Common Stock & APIC | 2.84M | 2.83M | 2.83M | 2.83M | 2.78M |
| Retained Earnings | -10.82M | -10.62M | -10.43M | -10.26M | -10.06M |
| Treasury Stock & Other | -202.50K | -184.00K | -232.80K | 29.60K | 286.80K |
| Total Common Equity | -8.18M | -7.97M | -7.83M | -7.40M | -6.99M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.18M | -7.97M | -7.83M | -7.40M | -6.99M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.18M | -7.97M | -7.83M | -7.40M | -6.99M |
|
|
|||||
